M. Kabir

Ovarian cancer serum biomarker discovery using proteomics

M. Kabir, 2008 .

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies

F. Kronenberg, E. Fung, I. Jacobs, 2014, Proteomics. Clinical applications.

Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor.

Hendrik Neubert, Adriaan Cleton, Musarat Kabir, 2013, Analytical chemistry.

Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS.

Hendrik Neubert, Musarat Kabir, Steven W. Martin, 2012, Analytical chemistry.

Serum Peptide Profiling using MALDI Mass Spectrometry

Rainer Cramer, Celia J. Smith, Usha Menon, 2007, Proteomics.

Serum Proteomic Abnormality Predating Screen Detection of Ovarian Cancer

Alexander Gammerman, Vladimir Vovk, Ilia Nouretdinov, 2009, Comput. J..